Progressive Pulmonary Infiltrates in a Man with Mediastinal Lymphoma.
作者信息
Walti Carla S, Cheng Guang-Shing, Gopal Ajay K, Hill Joshua A
机构信息
Vaccine and Infectious Disease Division and.
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; and.
出版信息
Ann Am Thorac Soc. 2021 May;18(5):884-888. doi: 10.1513/AnnalsATS.202008-1012CC.
Abstract
摘要
相似文献
1
Progressive Pulmonary Infiltrates in a Man with Mediastinal Lymphoma.
Ann Am Thorac Soc. 2021 May;18(5):884-888. doi: 10.1513/AnnalsATS.202008-1012CC.
2
Differentiation of lymphoma from histoplasmosis in children with mediastinal masses.
J Pediatr. 1984 May;104(5):706-9. doi: 10.1016/s0022-3476(84)80948-8.
3
Primary mediastinal large B-cell lymphoma mimicking liposarcoma.
Med Oncol. 2008;25(3):284-6. doi: 10.1007/s12032-007-9032-0. Epub 2007 Dec 8.
4
Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.
Ann Oncol. 1994 May;5(5):433-6. doi: 10.1093/oxfordjournals.annonc.a058875.
5
[Bilateral hilar and mediastinal lymphoma with pulmonary infiltration].
Radiologe. 1993 Apr;33(4):223-5.
6
Conventional roentgen diagnosis of mediastinal lymphadenopathy. Review article (part one).
Lymphology. 1982 Dec;15(4):132-42.
7
[Case contribution on the differential diagnosis of mediastinal tumors].
Z Tuberk Erkr Thoraxorg. 1968;129(1):39-47.
8
Mediastinal masses.
Surg Clin North Am. 1980 Aug;60(4):757-77. doi: 10.1016/s0039-6109(16)42181-x.
9
Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
Nouv Rev Fr Hematol (1978). 1993 Aug;35(4):457-61.
10
Extrinsic pulmonary stenosis in primary mediastinal B-cellular lymphoma.
J Clin Ultrasound. 2015 Jan;43(1):68-70. doi: 10.1002/jcu.22133. Epub 2014 Jan 22.
本文引用的文献
1
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
J Clin Oncol. 2019 Dec 1;37(34):3291-3299. doi: 10.1200/JCO.19.01389. Epub 2019 Oct 14.
2
Pneumonitis and concomitant bacterial pneumonia in patients receiving pembrolizumab treatment: Three case reports and literature review.
Medicine (Baltimore). 2019 Jun;98(25):e16158. doi: 10.1097/MD.0000000000016158.
3
Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic Trails.
Front Pharmacol. 2019 May 1;10:387. doi: 10.3389/fphar.2019.00387. eCollection 2019.
4
Management of Immunotherapy-Related Toxicities, Version 1.2019.
J Natl Compr Canc Netw. 2019 Mar 1;17(3):255-289. doi: 10.6004/jnccn.2019.0013.
5
Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies.
Clin Infect Dis. 2019 Aug 30;69(6):909-920. doi: 10.1093/cid/ciy1025.
6
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923.
7
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
8
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J. 2017 Aug 10;50(2). doi: 10.1183/13993003.00050-2017. Print 2017 Aug.
9
PD-1 inhibitor-related pneumonitis in lymphoma patients treated with single-agent pembrolizumab therapy.
Br J Haematol. 2018 Mar;180(5):752-755. doi: 10.1111/bjh.14441. Epub 2016 Nov 11.
10
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
J Clin Oncol. 2017 Mar;35(7):709-717. doi: 10.1200/JCO.2016.68.2005. Epub 2016 Sep 30.
Zotero 插件